Caricamento...
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes
Vav1 is physiologically active as a GDP/GTP nucleotide exchange factor (GEF) in the hematopoietic system. Overexpression of Vav1 in multiple tumor types is known to enhance oncogenicity, yet whether or not Vav1 is a bona fide oncogene is still a matter of debate. Although mutations in Vav1 were rece...
Salvato in:
| Pubblicato in: | Oncogenesis |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175932/ https://ncbi.nlm.nih.gov/pubmed/30297765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-018-0091-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|